Factors associated with testicular self-examination among unaffected men from multiple-case testicular cancer families

Hereditary Cancer in Clinical Practice

Volumn 7, Issue 1, 2009, Pages

  Vadaparampil, Susan T ^a   Moser, Richard P ^b   Loud, Jennifer ^b   Peters, June A ^b   Greene, Mark H ^b   Korde, Larissa ^b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER FAMILY; CANCER RISK; FAMILY HISTORY; HEALTH BELIEF; HIGH RISK POPULATION; HUMAN; KNOWLEDGE; MALE; NORMAL HUMAN; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; SELF EXAMINATION; SOCIAL PSYCHOLOGY; TESTIS CANCER;

EID: 77950296420     PISSN: 17312302     EISSN: 18974287     Source Type: Journal    
DOI: 10.1186/1897-4287-7-11     Document Type: Article

References (51)

1. Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LA, Schrag D, Jamison PM, Jemal A, Wu XC, Friedman C, Harlan L, Warren J, Anderson RN, Pickle LW. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 2005, 97:1407-27.
2. Purdue MP, Devesa SS, Sigurdson AJ, McGlynn KA. International patterns and trends in testis cancer incidence. Int J Cancer 2005, 115:822-7. 10.1002/ijc.20931, 15704170.
3. ACS Cancer facts and figures - 2007. 2007, (ACS Publication No. 5008.07). Atlanta, GA: American Cancer Society, ACS.
4. Ries LAG, Harkins D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, Eisner MP, Horner MJ, Howlader N, Hayat M, . ed SEER Cancer Statistics Review, 1975-2003. 2006, Bethesda, MD: National Cancer Institute, ed.
5. Molina Saera J, Aparicio Urtasun J, Diaz Beveridge R, Palomar Abad L, Gimenez Ortiz A, Ponce Lorenzo J, Montalar Salcedo J. Epidemiological pattern and time trends in testicular germ-cell tumors: a single institution 20-year experience. Clin Transl Oncol 2006, 8:588-93. 10.1007/s12094-006-0064-2, 16952847.
6. Moul JW, Paulson DF, Dodge RK, Walther PJ. Delay in diagnosis and survival in testicular cancer: impact of effective therapy and changes during 18 years. J Urol 1990, 143:520-3.
7. Ondrusova M, Ondrus D. Epidemiology and treatment delay in testicular cancer patients: a retrospective study. Int Urol Nephrol 2008, 40:143-148. 10.1007/s11255-007-9245-3, 17634758.
8. Adelman WP, Joffe A. Controversies in male adolescent health: varicocele, circumcision, and testicular self-examination. Curr Opin Pediatr 2004, 16:363-7. 10.1097/01.mop.0000131451.41322.43, 15273494.
9. Wishnow KI, Johnson DE, Preston WL, Tenney DM, Brown BW. Prompt orchiectomy reduces morbidity and mortality from testicular carcinoma. Br J Urol 1990, 65:629-33. 10.1111/j.1464-410X.1990.tb14834.x, 2164865.
10. Moul JW. Timely diagnosis of testicular cancer. Urol Clin North Am 2007, 34:109-17. 10.1016/j.ucl.2007.02.003, 17484916.
11. Chapple A, Ziebland S, McPherson A. Qualitative study of men's perceptions of why treatment delays occur in the UK for those with testicular cancer. Br J Gen Pract 2004, 54:25-32. 1314774, 14965403.
12. Vasudev NS, Joffe JK, Cooke C, Richards F, Jones WG. Delay in the diagnosis of testicular tumours - changes over the past 18 years. Br J Gen Pract 2004, 54:595-7. 1324839, 15296558.
13. Kramer JL, Greene MH, . ed Hereditary Testicular Cancer. Comprehensive Textbook of Genitourinary Oncology. 2006, Philadephia, PA: Lippincott, ed.
14. Dieckmann KP, Pichlmeier U. The prevalence of familial testicular cancer: an analysis of two patient populations and a review of the literature. Cancer 1997, 80:1954-60. 10.1002/(SICI)1097-0142(19971115)80:10<1954::AID-CNCR12>3.0.CO;2-X, 9366298.
15. Hemminki K, Chen B. Familial risks in testicular cancer as aetiological clues. Int J Androl 2006, 29:205-10. 10.1111/j.1365-2605.2005.00599.x, 16466541.
16. Hemminki K, Li X, Czene K. Familial risk of cancer: data for clinical counseling and cancer genetics. Int J Cancer 2004, 108:109-14. 10.1002/ijc.11478, 14618624.
17. Daly M, Axilbund JE, Bryant E, Buys S, Eng C, Friedman S, Esserman LJ, Farrell CD, Garber J, Jeter J, Kohlman W, Lynch PM, Marcom PK, Nabell LM, Osarogiagbon RU, Pasche B, Reiser G, Sutphen R, Weitzel JN. The NCCN Genetic/Familial High-Risk Assessment: Breast and Ovarian Clinical Practice Guideline, version 1.2006. 2006, http://www.nccn.org
18. Thomas DB, Gao DL, Ray RM, Wang WW, Allison CJ, Chen FL, Porter P, Hu YW, Zhao GL, Pan LD, Li W, Wu C, Coriaty Z, Evans I, Lin MG, Stalsberg H, Self SG. Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst 2002, 94:1445-57.
19. Blesch KS. Health beliefs about testicular cancer and self-examination among professional men. Oncol Nurs Forum 1986, 13:29-33.
20. Katz RC, Meyers K, Walls J. Cancer awareness and self-examination practices in young men and women. J Behav Med 1995, 18:377-84. 10.1007/BF01857661, 7500328.
21. Moore RA, Topping A. Young men's knowledge of testicular cancer and testicular self-examination: a lost opportunity?. Eur J Cancer Care (Engl) 1999, 8:137-42. 10.1046/j.1365-2354.1999.00151.x, 10763644.
22. Neef N, Scutchfield FD, Elder J, Bender SJ. Testicular self-examination by young men: an analysis of characteristics associated with practice. J Am Coll Health 1991, 39:187-90.
23. Rodriguez JG, Velez M, Serrano E, Casado MP. Adolescent student's compliance with testicular self examination. Bol Asoc Med P R 1995, 87:49-53.
24. Singer AJ, Tichler T, Orvieto R, Finestone A, Moskovitz M. Testicular carcinoma: a study of knowledge, awareness, and practice of testicular self-examination in male soldiers and military physicians. Mil Med 1993, 158:640-3.
25. Trumbo CW. Mass-mediated information effects on testicular self-examination among college students. J Am Coll Health 2004, 52:257-61. 10.3200/JACH.52.6.257-262, 15134099.
26. Ward KD, Weg MW, Read MC, Sell MA, Beech BM. Testicular cancer awareness and self-examination among adolescent males in a community-based youth organization. Prev Med 2005, 41:386-98. 10.1016/j.ypmed.2005.02.003, 15917035.
27. Crockford GP, Linger R, Hockley S, Dudakia D, Johnson L, Huddart R, Tucker K, Friedlander M, Phillips KA, Hogg D, Jewett MA, Lohynska R, Daugaard G, Richard S, Chompret A, Bonaiti-Pellie C, Heidenreich A, Albers P, Olah E, Geczi L, Bodrogi I, Ormiston WJ, Daly PA, Guilford P, Fossa SD, Heimdal K, Tjulandin SA, Liubchenko L, Stoll H, Weber W, Forman D, Oliver T, Einhorn L, McMaster M, Kramer J, Greene MH, Weber BL, Nathanson KL, Cortessis V, Easton DF, Bishop DT, Stratton MR, Rapley EA. Genome-wide linkage screen for testicular germ cell tumour susceptibility loci. Hum Mol Genet 2006, 15:443-51. 10.1093/hmg/ddi459, 16407372.
28. Janz NK, Champion VL, Strecher VJ, . ed The Health Belief Model. Health Behavior and Health Education. 2002, San Francisco, CA: Jossey-Bass, ed.
29. McClenahan C, Shevlin M, Adamson G, Bennett C, O'Neill B. Testicular self-examination: a test of the health belief model and the theory of planned behaviour. Health Educ Res 2007, 22:272-84. 10.1093/her/cyl076, 16885203.
30. Slovic P, Peters E, Finucane ML, Macgregor DG. Affect, risk, and decision making. Health Psychol 2005, 24:S35-40. 10.1037/0278-6133.24.4.S35, 16045417.
31. Korde LA, Premkumar A, Mueller C, Rosenberg P, Soho C, Bratslavsky G, Greene MH. Increased prevalence of testicular microlithiasis in men with familial testicular cancer and their relatives. Br J Cancer 2008, 99:1748-53. 10.1038/sj.bjc.6604704, 18841155.
32. Bazargan M, Bazargan SH, Calderon JL, Husaini BA, Baker RS. Mammography screening and breast self-examination among minority women in public housing projects: the impact of physician recommendation. Cell Mol Biol (Noisy-le-grand) 2003, 49:1213-8.
33. Manne S, Lessin S. Prevalence and correlates of sun protection and skin self-examination practices among cutaneous malignant melanoma survivors. J Behav Med 2006, 29:419-34. 10.1007/s10865-006-9064-5, 16855870.
34. Champion VL. Revised susceptibility, benefits, barriers scale for mammography screening. Res Nurs Health 1999, 22:341-8. 10.1002/(SICI)1098-240X(199908)22:4<341::AID-NUR8>3.0.CO;2-P, 10435551.
35. Wallston KA, Wallston BS, DeVellis R. Development of the Multidimensional Health Locus of Control (MHLC) Scales. Health Educ Monogr 1978, 6:160-70.
36. Lerman C, Daly M, Masny A, Balshem A. Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 1994, 12:843-50.
37. Horowitz M, Wilner N, Alvarez W. Impact of Event Scale: a measure of subjective stress. Psychosom Med 1979, 41:209-18.
38. Vadaparampil ST, Ropka M, Stefanek ME. Measurement of psychological factors associated with genetic testing for hereditary breast, ovarian and colon cancers. Fam Cancer 2005, 4:195-206. 10.1007/s10689-004-1446-7, 15951974.
39. McCullagh J, Lewis G, Warlow C. Promoting awareness and practice of testicular self-examination. Nurs Stand 2005, 19:41-9.
40. Aitken JF, Janda M, Lowe JB, Elwood M, Ring IT, Youl PH, Firman DW. Prevalence of whole-body skin self-examination in a population at high risk for skin cancer (Australia). Cancer Causes Control 2004, 15:453-63. 10.1023/B:CACO.0000036451.39128.f6, 15286465.
41. Manne S, Fasanella N, Connors J, Floyd B, Wang H, Lessin S. Sun protection and skin surveillance practices among relatives of patients with malignant melanoma: prevalence and predictors. Prev Med 2004, 39:36-47. 10.1016/j.ypmed.2004.02.028, 15207984.
42. Daly M, Axilbund JE, Bryant E, Buys S, Farrell CD, Ford JM, Friedman S, Garber J, Gruber S, Hampel H, Kaklamani V, Kohlmann W, Litton J, Marcom PK, Offitt K, Osarogiagbon RU, Pasche B, Reiser G, Shannon KM, Smith JR, Sutphen R, Weitzel JN. The NCCN Genetic/Familial High-Risk Assessment: Breast and Ovarian Clinical Practice Guideline, version 1.2009. 2009, To view most recent and complete version of guideline, to http://www.nccn.org.,http://www.nccn.org/professionals/physician-gls/PDF/genetics-screening.pdf
43. Champion VL, Scott CR. Reliability and validity of breast cancer screening belief scales in African American women. Nursing Research 1997, 46:331-337. 10.1097/00006199-199711000-00006, 9422052.
44. Aiken LS, West SG, Woodward CK, Reno RR. Health beliefs and compliance with mammography-screening recommendations in asymptomatic women. Health Psychol 1994, 13:122-9. 10.1037/0278-6133.13.2.122, 8020455.
45. Holm CJ, Frank DI, Curtin J. Health beliefs, health locus of control, and women's mammography behavior. Cancer Nurs 1999, 22:149-56. 10.1097/00002820-199904000-00007, 10217031.
46. Stein JA, Fox SA, Murata PJ, Morisky DE. Mammography usage and the health belief model. Health Educ Q 1992, 19:447-62.
47. Rudberg L, Nilsson S, Wikblad K, Carlsson M. Testicular cancer and testicular self-examination: knowledge and attitudes of adolescent Swedish men. Cancer Nurs 2005, 28:256-62. 10.1097/00002820-200507000-00003, 16046886.
48. Vadaparampil ST, Jacobsen PB, Kash K, Watson IS, Saloup R, Pow-Sang J. Factors predicting prostate specific antigen testing among first-degree relatives of prostate cancer patients. Cancer Epidemiol Biomarkers Prev 2004, 13:753-8.
49. Hay JL, Buckley TR, Ostroff JS. The role of cancer worry in cancer screening: a theoretical and empirical review of the literature. Psychooncology 2005, 14:517-34. 10.1002/pon.864, 15490428.
50. Bratt O, Damber JE, Emanuelsson M, Kristoffersson U, Lundgren R, Olsson H, Gronberg H. Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer. Eur J Cancer 2000, 36:235-41. 10.1016/S0959-8049(99)00272-5, 10741283.
51. Kinkade S. Testicular cancer. Am Fam Physician 1999, 59:2539-44. 2549-50, 10323360.